IBM to buy data company Truven Health Analytics for $2.6 bn
Advertisement
International Business Machines Corp said it would buy Truven Health Analytics, a provider of cloud-based healthcare data, for $2.6 billion, the company's fourth major health-related acquisition since launching the Watson Health unit in April last year.
Based in Ann Arbor, Michigan, Truven offers healthcare data and analytics solutions to U.S. federal and state government agencies, employers, hospitals and pharmaceutical companies.
IBM, whose healthcare unit is powered by the famous Watson supercomputer, will get access to more than 8,500 clients from the deal.
"With this acquisition, IBM will be the world's leading health data, analytics and insights company," Deborah DiSanzo, general manager for Watson Health said in a statement on Thursday.
IBM, which has been expanding aggressively in the healthcare IT sector, bought medical image company Merge Healthcare in a $1 billion deal in October.
In March, Reuters reported that Truven was preparing for an initial public offering it hoped would value the company at more than $3 billion, including debt, according to people familiar with the matter.
Based in Ann Arbor, Michigan, Truven offers healthcare data and analytics solutions to U.S. federal and state government agencies, employers, hospitals and pharmaceutical companies.
IBM, whose healthcare unit is powered by the famous Watson supercomputer, will get access to more than 8,500 clients from the deal.
"With this acquisition, IBM will be the world's leading health data, analytics and insights company," Deborah DiSanzo, general manager for Watson Health said in a statement on Thursday.
IBM, which has been expanding aggressively in the healthcare IT sector, bought medical image company Merge Healthcare in a $1 billion deal in October.
In March, Reuters reported that Truven was preparing for an initial public offering it hoped would value the company at more than $3 billion, including debt, according to people familiar with the matter.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.